ROHTO PHARMACEUTICAL CO LTD ROHTO PHARMACEUTICAL CO LTD ROHTO PHARMACEUTICAL CO LTD

ROHTO PHARMACEUTICAL CO LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.79 B‬EUR
0.84EUR
‪191.04 M‬EUR
‪1.90 B‬EUR
‪171.58 M‬
Beta (1Y)
0.49
Employees (FY)
‪9.14 K‬
Change (1Y)
‪+1.89 K‬ +25.97%
Revenue / Employee (1Y)
‪207.97 K‬EUR
Net income / Employee (1Y)
‪20.89 K‬EUR

About ROHTO PHARMACEUTICAL CO


CEO
Kunio Yamada
Headquarters
Osaka
Founded
1899
ISIN
JP3982400008
FIGI
BBG01TZ3PG34
Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others. The company was founded by Anmin Yamada on February 22, 1899 and is headquartered in Osaka, Japan.

Check out other big names from the same industry as UC1.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of UC1 is 12.00 EUR — it has decreased by −1.65% in the past 24 hours. Watch ROHTO PHARMACEUTICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ROHTO PHARMACEUTICAL CO LTD stocks are traded under the ticker UC1.
UC1 stock hasn't changed in a week, the month change is a −5.56% fall, over the last year ROHTO PHARMACEUTICAL CO LTD has showed a −5.51% decrease.
We've gathered analysts' opinions on ROHTO PHARMACEUTICAL CO LTD future price: according to them, UC1 price has a max estimate of 20.31 EUR and a min estimate of 10.15 EUR. Watch UC1 chart and read a more detailed ROHTO PHARMACEUTICAL CO LTD stock forecast: see what analysts think of ROHTO PHARMACEUTICAL CO LTD and suggest that you do with its stocks.
UC1 reached its all-time high on May 22, 2025 with the price of 12.90 EUR, and its all-time low was 11.70 EUR and was reached on Jul 10, 2025. View more price dynamics on UC1 chart.
See other stocks reaching their highest and lowest prices.
UC1 stock is 0.84% volatile and has beta coefficient of 0.49. Track ROHTO PHARMACEUTICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is ROHTO PHARMACEUTICAL CO LTD there?
Today ROHTO PHARMACEUTICAL CO LTD has the market capitalization of ‪2.70 B‬, it has increased by 1.24% over the last week.
Yes, you can track ROHTO PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
ROHTO PHARMACEUTICAL CO LTD is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ROHTO PHARMACEUTICAL CO LTD revenue for the last quarter amounts to ‪509.75 M‬ EUR, despite the estimated figure of ‪536.30 M‬ EUR. In the next quarter, revenue is expected to reach ‪461.78 M‬ EUR.
UC1 net income for the last quarter is ‪38.20 M‬ EUR, while the quarter before that showed ‪73.02 M‬ EUR of net income which accounts for −47.68% change. Track more ROHTO PHARMACEUTICAL CO LTD financial stats to get the full picture.
ROHTO PHARMACEUTICAL CO LTD dividend yield was 1.61% in 2024, and payout ratio reached 26.45%. The year before the numbers were 0.91% and 19.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 21, 2025, the company has ‪9.14 K‬ employees. See our rating of the largest employees — is ROHTO PHARMACEUTICAL CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROHTO PHARMACEUTICAL CO LTD EBITDA is ‪317.99 M‬ EUR, and current EBITDA margin is 16.72%. See more stats in ROHTO PHARMACEUTICAL CO LTD financial statements.
Like other stocks, UC1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROHTO PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.